Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - caspofungin -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - linezolid -

USA - engelsk - NLM (National Library of Medicine)

mayne pharma inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 5 mg - hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve hydrocodone bitartrate and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with: hydrocodone bitartrate and acetaminophen tablets contain hydrocodone, a schedule ii controlled substance. hydrocodone bitartrate and acetaminophen tablets contain hydrocodone, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol can be abused and is subject to misuse, addiction, and criminal diversion [see warnings ]. all patients treated with op

USA - engelsk - NLM (National Library of Medicine)

mayne pharma inc. - tamoxifen citrate (unii: 7frv7310n6) (tamoxifen - unii:094zi81y45) - tamoxifen 10 mg - tamoxifen citrate tablets are effective in the treatment of metastatic breast cancer in women and men. in premenopausal women with metastatic breast cancer, tamoxifen is an alternative to oophorectomy or ovarian irradiation. available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen therapy. tamoxifen citrate tablets are indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. in some tamoxifen adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes. tamoxifen citrate tablets are indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. the estrogen and progesterone receptor values may help to predict whether adjuvant tamoxifen therapy is likely to be beneficial. t

USA - engelsk - NLM (National Library of Medicine)

mayne pharma commercial llc - methamphetamine hydrochloride (unii: 997f43z9cv) (methamphetamine - unii:44ral3456c) - methamphetamine hydrochloride 5 mg - methamphetamine hydrochloride tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. in patients known to be hypersensitive to amphetamine, or other components of methamphetamine hydrochloride tablets. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetami

USA - engelsk - NLM (National Library of Medicine)

mayne pharma commercial llc - tamoxifen citrate (unii: 7frv7310n6) (tamoxifen - unii:094zi81y45) - tamoxifen citrate tablets are effective in the treatment of metastatic breast cancer in women and men. in premenopausal women with metastatic breast cancer, tamoxifen is an alternative to oophorectomy or ovarian irradiation. available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen therapy. tamoxifen citrate tablets are indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. in some tamoxifen adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes. tamoxifen citrate tablets are indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. the estrogen and progesterone receptor values may help to predict whether adjuvant tamoxifen therapy is likely to be beneficial. t

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - doxycycline hydrochloride -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - fosfomycin trometamol, quantity: 5.631 g - granules - excipient ingredients: saccharin; sucrose; flavour - monurol is indicated only for the treatment of acute uncomplicated lower urinary tract infections (acute cystitis) in females above 12 years of age caused by the following susceptible pathogens: escherichia coli or, enterococcus faecalis.,monurol is not indicated for the treatment of pyelonephritis or perinephric abscess or where resistance is likely (previous treatment failure, infection due to non-susceptible organism).,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to monurol. however, therapy may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. consideration should be given to the relevant clinical guidelines on the appropriate use of antibacterial agents.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - silodosin, quantity: 8 mg - capsule, hard - excipient ingredients: mannitol; sodium lauryl sulfate; magnesium stearate; gelatin; titanium dioxide; pregelatinised maize starch - urorec is indicated for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia in adult men

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - silodosin, quantity: 4 mg - capsule, hard - excipient ingredients: mannitol; sodium lauryl sulfate; magnesium stearate; gelatin; titanium dioxide; iron oxide yellow; pregelatinised maize starch - urorec is indicated for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia in adult men